Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 15Vitamin D Deficiency 13Prostatic Neoplasms 13Polycystic Ovary Syndrome 8Neoplasms 7Osteoporosis 4Colorectal Neoplasms 4Warts 3Rectal Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colonic Neoplasms 3Brain Neoplasms 3Male Urogenital Diseases 2Leukemia 2Cardiovascular Diseases 2Adenomatous Polyps 2Stroke 1Spinal Cord Injuries 1Skin Neoplasms 1Seizures 1Psoriasis 1Prostate Adenocarcinoma 1Premature Birth 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Pathologic Processes 1Pain 1Osteoarthritis 1

Interventions

padeliporfin 4Lycopene 3Vitamin E 2Tea 2Selenium 2Cholecalciferol 2Therapeutics 1Sugars 1Intraoperative Neurophysiological Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Male Urogenital Diseases × Cholecalciferol × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡